Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NPC1 | O15118 | 4/20 | 0.48 |
| ▸ | RAB9A | P51151 | 3/20 | 0.48 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.48 |
| ▸ | ALOX15 | P16050 | 2/20 | 0.48 |
| ▸ | LMNA | P02545 | 1/20 | 0.48 |
| ▸ | TP53 | P04637 | 1/20 | 0.48 |
| ▸ | CASP3 | P42574 | 1/20 | 0.48 |
| ▸ | SENP8 | Q96LD8 | 1/20 | 0.48 |
| ▸ | SENP7 | Q9BQF6 | 1/20 | 0.48 |
| ▸ | SENP6 | Q9GZR1 | 1/20 | 0.48 |
| ▸ | TSHR | P16473 | 1/20 | 0.48 |
| ▸ | UBE2T | Q9NPD8 | 1/20 | 0.47 |
| ▸ | ASIC3 | Q9UHC3 | 1/20 | 0.47 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.47 |
| ▸ | FBP1 | P09467 | 2/20 | 0.45 |
| ▸ | LOXL2 | Q9Y4K0 | 1/20 | 0.45 |
| ▸ | MEN1 | O00255 | 2/20 | 0.44 |
| ▸ | MAPT | P10636 | 2/20 | 0.44 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.44 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL16851750 | 0.87 | NPC1 (0.48) | NPC1RAB9ASMN1; SMN2ALOX15LMNA | |
| SCHEMBL15722636 | 0.84 | NPC1 (0.52) | NPC1RAB9ASMN1; SMN2ALOX15LMNA | |
| SCHEMBL18369556 | 0.83 | NPC1 (0.51) | NPC1RAB9ASMN1; SMN2ALOX15LMNA | |
| SCHEMBL10387972 | 0.82 | CYP3A4 (0.52) | NPC1RAB9ASMN1; SMN2ALOX15LMNA | |
| SCHEMBL16705585 | 0.82 | L3MBTL1 (0.52) | NPC1RAB9ASMN1; SMN2ALOX15LMNA | |
| SCHEMBL23185863 | 0.82 | NPC1 (0.50) | NPC1RAB9ASMN1; SMN2ALOX15LMNA | |
| SCHEMBL16705693 | 0.82 | NPC1 (0.50) | NPC1RAB9ASMN1; SMN2ALOX15LMNA | |
| SCHEMBL15722747 | 0.82 | NPC1 (0.50) | NPC1RAB9ASMN1; SMN2ALOX15LMNA | |
| SCHEMBL15722637 | 0.82 | NPC1 (0.50) | NPC1RAB9ASMN1; SMN2ALOX15LMNA | |
| SCHEMBL9037879 | 0.81 | NPC1 (0.53) | NPC1RAB9ASMN1; SMN2ALOX15LMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 15 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-118702646-A | Novel polymerizable liquid crystal | 罗利克技术有限公司 | 2024-09-27 | — | — | CN | disclosed |
| CN-114026078-B | Novel polymerizable liquid crystal | 罗利克技术有限公司 | 2024-06-07 | — | — | CN | disclosed |
| US-11370740-B2 | Method for producing ester group-containing compound | DIC CORPORATION (JP) | 2022-06-28 | — | — | US | disclosed |
| EP-3990569-A1 | NEW POLYMERIZABLE LIQUID CRYSTAL | Rolic Technologies AG (CH) | 2022-05-04 | — | — | EP | disclosed |
| CN-114026078-A | Novel polymerizable liquid crystal | 罗利克技术有限公司 | 2022-02-08 | — | — | CN | disclosed |
| US-11091452-B2 | Polymerizable compound, polymerizable composition, polymer, optically anisotropic body, and method for producing polymerizable compound | ZEON CORPORATION (JP) | 2021-08-17 | — | — | US | disclosed |
| US-10577306-B2 | Mixture of polymerizable compound and method of producing the same | ZEON CORPORATION (JP) | 2020-03-03 | — | — | US | disclosed |
| US-20200048213-A1 | POLYMERIZABLE COMPOUND, POLYMERIZABLE COMPOSITION, POLYMER, OPTICALLY ANISOTROPIC BODY, AND METHOD FOR PRODUCING POLYMERIZABLE COMPOUND | ZEON CORPORATION (JP) | 2020-02-13 | — | — | US | disclosed |
| US-10173992-B2 | Polymerizable compound, polymerizable composition, polymer, optically anisotropic body, and method for producing polymerizable compound | ZEON CORPORATION (JP) | 2019-01-08 | — | — | US | disclosed |
| EP-2871192-B1 | POLYMERIZABLE COMPOUND, POLYMERIZABLE COMPOSITION, POLYMER, OPTICALLY ANISOTROPIC BODY, AND METHOD FOR PRODUCING POLYMERIZABLE COMPOUND | ZEON CORP (JP) | 2018-06-20 | — | — | EP | disclosed |
| US-20180099921-A1 | MIXTURE OF POLYMERIZABLE COMPOUND AND METHOD OF PRODUCING THE SAME | ZEON CORPORATION (JP) | 2018-04-12 | — | — | US | disclosed |
| US-9586917-B2 | Polymerizable compound, polymerizable composition, polymer, optically anisotropic body, and method for producing polymerizable compound | ZEON CORPORATION (JP) | 2017-03-07 | — | — | US | disclosed |
| US-20160280672-A1 | POLYMERIZABLE COMPOUND, POLYMERIZABLE COMPOSITION, POLYMER, OPTICALLY ANISOTROPIC BODY, AND METHOD FOR PRODUCING POLYMERIZABLE COMPOUND | ZEON CORPORATION (JP) | 2016-09-29 | — | — | US | disclosed |
| US-20150175564-A1 | POLYMERIZABLE COMPOUND, POLYMERIZABLE COMPOSITION, POLYMER, OPTICALLY ANISOTROPIC BODY, AND METHOD FOR PRODUCING POLYMERIZABLE COMPOUND | ZEON CORPORATION (JP) | 2015-06-25 | — | — | US | disclosed |
| EP-2871192-A1 | POLYMERIZABLE COMPOUND, POLYMERIZABLE COMPOSITION, POLYMER, OPTICALLY ANISOTROPIC BODY, AND METHOD FOR PRODUCING POLYMERIZABLE COMPOUND | Zeon Corporation (JP) | 2015-05-13 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (8 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10173992-B2 | Polymerizable compound, polymerizable composition, polymer, optically anisotropic body, and method for producing polymerizable compound | PYM1, C5, C1S | NPC1 3672/4885RAB9A 3942/4885SMN1; SMN2 3641/4885 |
| US-20180099921-A1 | MIXTURE OF POLYMERIZABLE COMPOUND AND METHOD OF PRODUCING THE SAME | DDT, CA4, DNMT3B | NPC1 3990/4885RAB9A 2949/4885SMN1; SMN2 3717/4885 |
| US-20200048213-A1 | POLYMERIZABLE COMPOUND, POLYMERIZABLE COMPOSITION, POLYMER, OPTICALLY ANISOTROPIC BODY, AND METHOD FOR PRODUCING POLYMERIZABLE COMPOUND | PDE8A, MAPT, PLK4 | NPC1 3200/4885RAB9A 3436/4885SMN1; SMN2 1961/4885 |
| US-11091452-B2 | Polymerizable compound, polymerizable composition, polymer, optically anisotropic body, and method for producing polymerizable compound | PDE8A, MAPT, PLK4 | NPC1 3200/4885RAB9A 3436/4885SMN1; SMN2 1961/4885 |
| US-11370740-B2 | Method for producing ester group-containing compound | COASY, TAF5, TAF9 | NPC1 404/4885RAB9A 2782/4885SMN1; SMN2 3549/4885 |
| US-20160280672-A1 | POLYMERIZABLE COMPOUND, POLYMERIZABLE COMPOSITION, POLYMER, OPTICALLY ANISOTROPIC BODY, AND METHOD FOR PRODUCING POLYMERIZABLE COMPOUND | PYM1, C5, C1S | NPC1 3672/4885RAB9A 3942/4885SMN1; SMN2 3641/4885 |
| US-20150175564-A1 | POLYMERIZABLE COMPOUND, POLYMERIZABLE COMPOSITION, POLYMER, OPTICALLY ANISOTROPIC BODY, AND METHOD FOR PRODUCING POLYMERIZABLE COMPOUND | PYM1, C5, C1S | NPC1 3672/4885RAB9A 3942/4885SMN1; SMN2 3641/4885 |
| US-10577306-B2 | Mixture of polymerizable compound and method of producing the same | DDT, CA4, DNMT3B | NPC1 3990/4885RAB9A 2949/4885SMN1; SMN2 3717/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.